MODIFICATION TO: NUCAMMA RX— 510(k) K032779

Substantially Equivalent

Is2 Research, Inc.

FDA 510(k) clearance K032779 for MODIFICATION TO: NUCAMMA RX, Substantially Equivalent on 2003-12-17. Applicant: Is2 Research, Inc..

Clearance details

Applicant: Is2 Research, Inc.
Product code: Code KPS
Advisory panel: Radiology
Date received: 2003-09-08
Decision date: 2003-12-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Ottawa, Ontario, CA

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.